Sep 14, 2023 / 08:05AM GMT
Graham Glyn Charles Parry - BofA Securities, Research Division - MD and Head of Healthcare Equity Research
Good morning, everybody, and welcome to Session 2 of the second day of the Bank of America Global Healthcare Conference today. It's my pleasure to be able to introduce our first European company this orning, which is GSK. And from GSK, we've got Emma Walmsley, CEO. We also have a new CFO, Julie Brown, sitting in the front here, and Nick from IR as well.
So perhaps, Emma, welcome. It's a pleasure to have you here as always, an annual event. Perhaps it would be worthwhile, just a couple of opening remarks from you, just thoughts on where GSK is at the moment and where you're executing against your plan.
Emma Natasha Walmsley - GSK plc - CEO & Director
Yes. Well, first of all, thank you very much, everybody, for joining us this morning. Great to see you. And I would say the headline is we're feeling good. We are delivering on all of the commitments that we've laid out in the transformation journey for GSK, most foundationally a step change in
GSK plc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers